CRL
Charles River Laboratories International, Inc. · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding):
keluasan pemegang +11.1% ·
aliran saham +11.8% ·
posisi baru bersih +10.0%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 138 | -1 | 45.11M | $10.22B | +6 | −8 |
| Q1 2026 | 143 | -7 | 45.52M | $7.86B | +6 | −14 |
| Q4 2025 | 150 | +3 | 43.69M | $8.72B | +4 | — |
| Q3 2025 | 22 | 0 | 23.18M | $3.62B | +1 | −2 |
| Q2 2025 | 20 | +2 | 21.36M | $3.24B | +4 | −2 |
| Q1 2025 | 15 | 0 | 9.57M | $1.44B | +1 | −1 |
| Q4 2024 | 15 | +1 | 9.65M | $1.78B | +1 | — |
| Q3 2024 | 13 | -1 | 6.67M | $1.31B | — | −1 |
| Q2 2024 | 14 | — | 3.92M | $810.09M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 5.81M | — | $881.82M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 2 | Wellington Management ✦ | 3.77M | -12.1% | $571.69M | 0.1% | ▼ Trim | 5 | SEC ↗ ×8 |
| 3 | BlackRock ✦ (pasif) | 3.66M | — | $554.74M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 4 | State Street Global Advisors ✦ (pasif) | 1.86M | -2.3% | $282.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 1.23M | -2.5% | $186.60M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Harris Associates (Oakmark) ✦ | 1.16M | Baru | $176.45M | 0.3% | New | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 607.02K | Baru | $92.10M | 0.1% | New | 1 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 578.61K | +63.6% | $87.79M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 564.59K | +100.2% | $85.67M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 507.32K | +580.9% | $76.98M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | Norges Bank ✦ (pasif) | 507.16K | +15.8% | $76.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | PRIMECAP Management ✦ | 270.60K | -0.8% | $41.06M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 269.16K | +73.9% | $40.84M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 236.41K | Baru | $35.87M | 0.1% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 93.67K | -42.6% | $14.21M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 78.32K | — | $11.88M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 17 | T. Rowe Price ✦ | 74.47K | -2.0% | $11.30M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 45.00K | Baru | $6.83M | 0.0% | New | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 26.76K | +329.1% | $4.02M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 20 | Marshall Wace ✦ | 14.07K | -62.9% | $2.14M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Harris Associates (Oakmark) | $176.45M | 0.3% |
| D. E. Shaw & Co. | $92.10M | 0.1% |
| Point72 Asset Management | $35.87M | 0.1% |
| Adage Capital Partners | $6.83M | 0.0% |
Telah keluar
| Fisher Asset Management | $38.42M | adalah 0.0% |
| Baillie Gifford | $7,375 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 555 pemegang, 56.84M saham, $9.32B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Officer · EVP & Chief Financial… · 10 lbr @ 297.43 · $2,974
Penjualan di pasar terbuka (S)
Officer · 981 lbr · $302,580
Director · 33.56K lbr · $10.07M
Officer · 2.04K lbr · $599,711
Director · 573 lbr · $163,443
Officer, Director · 6.50K lbr · $1.82M
Officer · 3.71K lbr · $1.04M
Director · 28.73K lbr · $7.90M
Officer · 620 lbr · $163,643
Officer · 482 lbr · $127,812
Officer · 404 lbr · $104,446
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi